Immunosuppressants and Cancer Recurrence: New Evidence on Monitoring and Risks
April 20, 2026
Alyssa Penford
0 Comments
Explore the evolution of cancer recurrence monitoring and the use of immunosuppressants. Learn why the old "five-year rule" is outdated based on new clinical data.
